Early treatment of rituximab combined with eltrombopag for secondary thrombocytopenic purpura in rheumatoid arthritis: A case report

RATIONALE: Secondary immune thrombocytopenic purpura (ITP) is also known as acquired thrombocytopenic purpura, autoimmune disease is usually one of the important causes. There are few reports about treatment of refractory thrombocytopenic purpura in rheumatoid arthritis (RA). We report a case of ref...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Naidan, Ji, Chaixia, Bao, Xiao, Yuan, Chengliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
6900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757979/
https://www.ncbi.nlm.nih.gov/pubmed/35029180
http://dx.doi.org/10.1097/MD.0000000000028417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757979/
https://www.ncbi.nlm.nih.gov/pubmed/35029180
http://dx.doi.org/10.1097/MD.0000000000028417

Ejemplares similares